Sanofi Ends Autoimmune Disease Drug Program
Nurix says Sanofi is ending its program related to drugs for autoimmune diseases.
Related stories
HP Names GSK’s Wolmsley CEO; Shares Surge More Than 6%
HP named GSK’s Wolmsley CEO, replacing interim CEO Bruce Broussard. Broussard will succeed Chip Bergh as board chair. HP shares surged more than 6%.
M impact | EQUITY | Nov 04, 2026, 07:47 PM UTC
HP Names GSK Veteran Walmsley CEO; Shares Jump Over 6%
HP named Walmsley, a GSK restructuring veteran, as CEO, and its shares rose over 6%.
M impact | EQUITY | Nov 04, 2026, 07:46 PM UTC
Dollar Tree and Discount Retailers Rally; Gains Reported for Four Stocks
Dollar Tree rose 8.3%, Dollar General 7.0%, TJX 5.9% and Ross Stores 6.2%.
M impact | EQUITY | Nov 04, 2026, 07:45 PM UTC
Wall Street Rises After Democrats Win Congress; Data Center Stocks Tumble
M impact | EQUITY | Nov 04, 2026, 07:44 PM UTC
Global Industrial shares rise after Q3 results top estimates
M impact | EQUITY | Nov 04, 2026, 07:43 PM UTC
CS Disco Shares Rise Nearly 18% After Q3 Results Improve
CS Disco shares rose nearly 18% after its third-quarter results improved.
M impact | EQUITY | Nov 04, 2026, 07:43 PM UTC